Ingredients: Analysis of active ingredients, intermediates, and excipients in pharmaceutical development and manufacturing - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Ingredients
Trends, market analysis, and market growth reports on pharmaceutical ingredient suppliers and manufacturers. Sourcing and supply of active pharmaceutical ingredients (APIs), intermediates, excipients.

CPhI 2014 Highlights

November 17, 2014

Selected new technologies, products, and facilities from CPhI Worldwide 2014 are reviewed.

FDA Issues Warning Letter to Cadila Pharmaceuticals for CGMP Deviations

November 13, 2014

The agency cites deviations from CGMPs for the manufacture of APIs at the company?s Gujarat, India plant.

Advances in Large-Scale Heterocyclic Synthesis

November 2, 2014

Pharmaceutical Technology

New practical approaches to the synthesis of complex heterocycles are reviewed.

Fluorination Remains Key Challenge in API Synthesis

October 2, 2014

Pharmaceutical Technology

Safer fluorinating reagents and access to GMP fluorination capabilities remain challenges in API synthesis.

Asymmetric Synthesis Continues to Advance

September 2, 2014

Pharmaceutical Technology

A survey of the recent literature reveals numerous advances in asymmetric chemocatalysis.

QbD in API Manufacturing

September 2, 2014

Pharmaceutical Technology

With a quality-by-design approach, robust processes consistently can help deliver quality product.

Meeting the Challenges of Excipient Variability

September 1, 2014

Pharmaceutical Technology

The quality and composition of excipients can vary due to environmental factors, processing methods, raw material quality, manufacturing location changes, and even operator actions.

Exploring a New Approval Process for Continued Excipient Innovation

September 1, 2014

Pharmaceutical Technology

New excipients and improvements to existing excipients are needed to facilitate access to new drugs for patients.

API Developers Pass Inspections and Upgrade Capabilities

September 1, 2014

Pharmaceutical Technology

API development and manufacturing companies expanded their capabilities, built partnerships, and achieved milestones in regulatory inspections.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
Click here